May 11, 2026 04:01PM
Nov 3, 2025 04:01PM
Aug 5, 2025 04:01PM
May 6, 2025 04:01PM
Feb 18, 2025 04:01PM
Jan 8, 2025 07:00AM
Aug 6, 2024 04:01PM HALOZYME REPORTS SECOND QUARTER 2024 FINANCIAL AND OPERATING RESULTS
May 7, 2024 04:01PM
Feb 20, 2024 04:01PM
Nov 6, 2023 04:01PM
Aug 8, 2023 04:01PM
May 9, 2023 04:01PM
Feb 21, 2023 04:01PM
Jan 10, 2023 05:15PM Halozyme Provides 2023 Financial Guidance and Outlook
Nov 8, 2022 04:01PM
Aug 16, 2022 05:56AM
Aug 15, 2022 10:32PM
Aug 15, 2022 07:01AM
Aug 15, 2022 07:00AM
Aug 9, 2022 04:01PM
May 12, 2022 08:03AM Halozyme Therapeutics (HALO) Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of Antares Pharma (ATRS)
May 12, 2022 08:00AM
May 10, 2022 04:01PM
Apr 26, 2022 08:00AM
Apr 13, 2022 06:00AM
Apr 13, 2022 06:00AM
Feb 22, 2022 04:01PM
Jan 10, 2022 08:00AM HALOZYME PROVIDES 2022 FINANCIAL GUIDANCE AND OUTLOOK
Dec 9, 2021 04:01PM
Dec 9, 2021 04:01PM
Nov 2, 2021 04:01PM
Aug 9, 2021 04:01PM
May 10, 2021 04:01PM
Feb 24, 2021 10:41PM
Feb 23, 2021 04:10PM Halozyme Therapeutics (HALO) Announces Proposed Offering of $500 Million of Convertible Senior Notes due 2027
Feb 23, 2021 04:10PM
Feb 23, 2021 04:01PM
Jan 11, 2021 09:14AM
Jan 11, 2021 08:00AM
Nov 2, 2020 04:01PM
Aug 10, 2020 04:01PM
May 11, 2020 04:01PM Halozyme Reports First Quarter 2020 Results
Feb 24, 2020 04:23PM
Feb 24, 2020 04:02PM
Feb 24, 2020 04:01PM
Jan 14, 2020 08:07AM
Jan 14, 2020 08:00AM
Nov 12, 2019 04:01PM
Nov 4, 2019 07:03AM Halozyme Therapeutics (HALO) to initiate organizational restructuring to halt development activities for PEGPH20 and close its oncology operations
Nov 4, 2019 07:00AM

100,144 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All